DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Haneda M, Seino Y, Inagaki N. et al.
Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus.
Clinical Therapeutics 2016;
38: 66-88
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.